Robin Shane Readnour, Director at AN2 Therapeutics, Inc., holds 514.79K shares in AN2 Therapeutics, Inc. (Ticker: ANTX). Most recently, Robin Shane Readnour Bought $200,000 shares of AN2 Therapeutics, Inc. on Nov 21, 2024 for an estimated value of 212.25K.
What is the percentage of profitable transactions made by Robin Shane Readnour?
The percentage of profitable transactions made by Robin Shane Readnour is 50%.
What is the average return per transaction made by Robin Shane Readnour?
The average return per transaction made by Robin Shane Readnour is -12.80%.
What stocks does Robin Shane Readnour hold?
Robin Shane Readnour holds: ANTX stocks.
What was Robin Shane Readnour’s latest transaction?
Robin Shane Readnour latest transaction was an Informative Buy of $212.25K.
What was Robin Shane Readnour's most profitable transaction?
Robin Shane Readnour’s most profitable transaction was an Informative Buy of ANTX stock on November 21, 2024. The return on the trade was 8.90%.
What is Robin Shane Readnour's role in AN2 Therapeutics, Inc.?
Robin Shane Readnour's role in AN2 Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.